BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 5718841)

  • 1. [Effects of administration of phosphocreatine on the clinical, biochemical and electromyographic evolution of Duchenne's progressive muscular dystrophy].
    Radu H; Keresztes L; Stenzel K
    Minerva Med; 1968 Dec; 59(99):5524-9. PubMed ID: 5718841
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of drug administration on the child with progressive muscular dystrophy].
    Nakahara T; Annaka S; Baba T; Kanno M
    Iryo; 1969 Oct; 23(10):1319-27. PubMed ID: 5364983
    [No Abstract]   [Full Text] [Related]  

  • 3. [Plasmatic enzyme studies in individuals with progressive muscular dystrophy in the course of various therapeutic trials].
    Mancini G; Lapi AS; Schwarzenberg TL; Canibus R; Natoli V
    Arch Ital Pediatr Pueric; 1968; 26(1):36-46. PubMed ID: 5737311
    [No Abstract]   [Full Text] [Related]  

  • 4. [Progressive musclar dystrophy in the experience of the Pediatric Clinic of Florence. Longitudinal study of 43 subjects].
    Adami Lami Conti C; Calandi C; Nistri R; Aulisi A; Bucciolini MG; Vannelli G; Ragazzini F
    Minerva Pediatr; 1981 May; 33(9):385-412. PubMed ID: 7019663
    [No Abstract]   [Full Text] [Related]  

  • 5. [Long-term hypertransaminasemia disclosing a muscular disease].
    Odièvre M; Rivron M; Landrieu P
    Arch Fr Pediatr; 1987; 44(6):453-4. PubMed ID: 3619584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Progressive muscular dystrophy: CPK, LDH, ALD (aldolase)--EMG, ECG in patients and their families].
    Diotallevi P; Bargilli E; Danni M; Dellantonio R; Tocchini M; Milani-Comparetti M
    Boll Soc Ital Biol Sper; 1988 Jun; 64(6):523-30. PubMed ID: 3190905
    [No Abstract]   [Full Text] [Related]  

  • 7. [Evaluation of serum pyruvate kinase in patients with Duchenne's muscular dystrophy and carriers. Comparison with other enzyme determinations].
    Calandi C; Adami Lami C; Guidotti T; Nistri R; Papuzza S; Tozzi P; Poggi G
    Minerva Pediatr; 1981 May; 33(10):453-64. PubMed ID: 7254147
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical experimental studies of the activity of a cellular extract (TRF). 3. Activity in muscular diseases].
    Del Giudice E; De Luca R; Del Prete A; Sepe O; Federico P; Portone N; Spagnoletti G
    Boll Soc Ital Biol Sper; 1968 Nov; 44(22):1868-71. PubMed ID: 5735735
    [No Abstract]   [Full Text] [Related]  

  • 9. [Serum enzyme activities in progressive muscular dystrophy].
    Yano I; Furukawa Y; Masaki H; Tani J
    Nihon Rinsho; 1966 Mar; 24(3):571-5. PubMed ID: 6007312
    [No Abstract]   [Full Text] [Related]  

  • 10. Slowly progressive X-linked recessive muscular dystrophy (type 3b). Report of cases and review of the literature.
    Zellweger H; Hanson JW
    Arch Intern Med; 1967 Nov; 120(5):525-35. PubMed ID: 6054585
    [No Abstract]   [Full Text] [Related]  

  • 11. [Diagnosis of female carriers of Duchenne's progressive muscular dystrophy using discriminative analysis of various serum enzyme activities].
    Büsing CM; Heyck H; Laudahn G
    Klin Wochenschr; 1969 Oct; 47(20):1099-103. PubMed ID: 5381991
    [No Abstract]   [Full Text] [Related]  

  • 12. Variable effects of corticosteroid treatment of serum enzyme activities in Duchenne's muscular dystrophy.
    Cohen L; Morgan J; Bozyk ME
    Res Commun Chem Pathol Pharmacol; 1977 Jul; 17(3):529-38. PubMed ID: 70832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Serum enzyme activities in the families of patients with progressive muscular dystrophy].
    Tani J; Yano I; Masaki H; Fukuyama K; Saeki B
    Iryo; 1967 Jul; 21(7):848-53. PubMed ID: 5582480
    [No Abstract]   [Full Text] [Related]  

  • 14. Biochemical aspects of genetically determined progressive muscular dystrophies.
    Luca N; Haţegan D
    Rev Roum Neurol; 1973; 10(6):531-7. PubMed ID: 4771091
    [No Abstract]   [Full Text] [Related]  

  • 15. [The muscle in rheumatoid polyarthritis. Biochemical and electromyographic study].
    Louyot P; Pourel J; Duc ML; Brichet G; Duc M
    Rev Rhum Mal Osteoartic; 1971 May; 38(5):331-44. PubMed ID: 4326484
    [No Abstract]   [Full Text] [Related]  

  • 16. [Becker's benign muscular dystrophy. Observations on 1 family].
    Armocida G; Cottini R; Finavera L; Majeron MA
    Minerva Med; 1978 May; 69(25):1745-8. PubMed ID: 662177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Progressive muscle dystrophy. II. Enzyme activity chages in serum in progressive muscle dystrophy].
    Lujf A; Sluga E; Moser K
    Wien Klin Wochenschr; 1971 Feb; 83(7):109-13. PubMed ID: 5547427
    [No Abstract]   [Full Text] [Related]  

  • 18. [Enzymatic activity of the serum in the family of a progressive muscular dystrophy patient].
    Esaki K; Tokoro T; Yamamoto K; Kato T; Asano B
    Iryo; 1969 Oct; 23(10):1306-11. PubMed ID: 5364982
    [No Abstract]   [Full Text] [Related]  

  • 19. [The treatment of progressive muscular dystrophy with nucleosides and nucleotides. Clinical and serologic findings (aldolase and creatinphosphokinase)].
    Ceccarelli A; Leone P; Moretti A
    Clin Pediatr (Bologna); 1967 Sep; 49(9):468-75. PubMed ID: 5608288
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of the simultaneous administration of diethylstilbestrol and prednisolone on serum enzymes in Duchenne's muscular dystrophy.
    Cohen L; Morgan J; Bozyk ME
    J Med; 1977; 8(2):123-34. PubMed ID: 268398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.